Prenatal aortic valvuloplasty as a definite treatment in fetuses with critical aortic stenosis, severe mitral regurgitation and giant left atrium: a report of two cases with medium-term follow-up.
Andreas TulzerWolfgang ArztGerald TulzerPublished in: Cardiology in the young (2022)
Fetuses with critical aortic stenosis, severe mitral regurgitation and left atrial enlargement are at risk to develop heart failure and intrauterine death. We present two cases with this physiology who underwent fetal aortic balloon valvuloplasty at 25 + 5 and 28 + 2 weeks as their only intervention without requiring postnatal treatment during short- to medium-term follow-up of 1.4 and 4.9 years.
Keyphrases
- aortic stenosis
- left ventricular
- aortic valve
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- left atrial
- ejection fraction
- heart failure
- gestational age
- preterm infants
- mitral valve
- coronary artery disease
- cardiac resynchronization therapy
- atrial fibrillation
- randomized controlled trial
- pulmonary artery
- combination therapy
- preterm birth
- pulmonary arterial hypertension
- inferior vena cava